Home

fluide Cinq Donner naissance cd90 marker Raccourcis Désaccord Becks

Frontiers | CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule
Frontiers | CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule

Human CD90/Thy1 Antibody MAB20671-100: R&D Systems
Human CD90/Thy1 Antibody MAB20671-100: R&D Systems

CD90 (Thy-1) Monoclonal Antibody (eBio5E10 (5E10)), FITC (11-0909-42)
CD90 (Thy-1) Monoclonal Antibody (eBio5E10 (5E10)), FITC (11-0909-42)

CD90/Thy1 Antibody (G7) [FITC] (NBP1-28032): Novus Biologicals
CD90/Thy1 Antibody (G7) [FITC] (NBP1-28032): Novus Biologicals

Integrin-α3 Is a Functional Marker of Ex Vivo Expanded Human Long-Te
Integrin-α3 Is a Functional Marker of Ex Vivo Expanded Human Long-Te

Expression of cancer stem cell markers CD44 and CD90 in gastric cancer... | Download Scientific Diagram
Expression of cancer stem cell markers CD44 and CD90 in gastric cancer... | Download Scientific Diagram

Sifting through the haystack: Optimizing hematopoietic stem cell purification for gene therapy
Sifting through the haystack: Optimizing hematopoietic stem cell purification for gene therapy

Surface Markers of Mesenchymal Stem Cells - Cusabio
Surface Markers of Mesenchymal Stem Cells - Cusabio

A quiescent cell population replenishes mesenchymal stem cells to drive accelerated growth in mouse incisors | Nature Communications
A quiescent cell population replenishes mesenchymal stem cells to drive accelerated growth in mouse incisors | Nature Communications

CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression | Cell Death & Disease
CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression | Cell Death & Disease

Expressions of CD44 and CD90 surface marker of synovial membrane (SM)... | Download Scientific Diagram
Expressions of CD44 and CD90 surface marker of synovial membrane (SM)... | Download Scientific Diagram

Figures and data in Full spectrum flow cytometry reveals mesenchymal heterogeneity in first trimester placentae and phenotypic convergence in culture, providing insight into the origins of placental mesenchymal stromal cells | eLife
Figures and data in Full spectrum flow cytometry reveals mesenchymal heterogeneity in first trimester placentae and phenotypic convergence in culture, providing insight into the origins of placental mesenchymal stromal cells | eLife

Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin
Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin

Cluster of differentiation in stem cells | Sino Biological
Cluster of differentiation in stem cells | Sino Biological

Human Mesenchymal Stem Cell Flow Cytometry Kit (FMC020-NOV): Novus Biologicals
Human Mesenchymal Stem Cell Flow Cytometry Kit (FMC020-NOV): Novus Biologicals

Anti Human CD90 Antibody, clone F15-42-1 | Bio-Rad
Anti Human CD90 Antibody, clone F15-42-1 | Bio-Rad

Anti Dog CD90 Antibody, clone YKIX337.217 | Bio-Rad
Anti Dog CD90 Antibody, clone YKIX337.217 | Bio-Rad

Very Bright Antibody to Detect CD90.1 Congenic Marker on T Cells | Biocompare Antibody Review
Very Bright Antibody to Detect CD90.1 Congenic Marker on T Cells | Biocompare Antibody Review

Frontiers | CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule
Frontiers | CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule

Comprehensive Cell Surface Protein Profiling Identifies Specific Markers of Human Naive and Primed Pluripotent States - ScienceDirect
Comprehensive Cell Surface Protein Profiling Identifies Specific Markers of Human Naive and Primed Pluripotent States - ScienceDirect

Overexpression of CD90 (Thy-1) in Pancreatic Adenocarcinoma Present in the Tumor Microenvironment | PLOS ONE
Overexpression of CD90 (Thy-1) in Pancreatic Adenocarcinoma Present in the Tumor Microenvironment | PLOS ONE

Very Bright Antibody to Detect CD90.1 Congenic Marker on T Cells | Biocompare Antibody Review
Very Bright Antibody to Detect CD90.1 Congenic Marker on T Cells | Biocompare Antibody Review

Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas | Stem Cells and Development
Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas | Stem Cells and Development

Purification of Human CD34+CD90+ HSCs Reduces Target Cell Population and Improves Lentiviral Transduction for Gene Therapy - ScienceDirect
Purification of Human CD34+CD90+ HSCs Reduces Target Cell Population and Improves Lentiviral Transduction for Gene Therapy - ScienceDirect

CD90 serves as differential modulator of subcutaneous and visceral adipose-derived stem cells by regulating AKT activation that influences adipose tissue and metabolic homeostasis | Stem Cell Research & Therapy | Full Text
CD90 serves as differential modulator of subcutaneous and visceral adipose-derived stem cells by regulating AKT activation that influences adipose tissue and metabolic homeostasis | Stem Cell Research & Therapy | Full Text

IJMS | Free Full-Text | Expression of Cancer Stem Cell Markers EpCAM and CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in Hepatocellular Carcinoma
IJMS | Free Full-Text | Expression of Cancer Stem Cell Markers EpCAM and CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in Hepatocellular Carcinoma

CD105+CD90+CD13+ identifies a clonogenic subset of adventitial lung fibroblasts | Scientific Reports
CD105+CD90+CD13+ identifies a clonogenic subset of adventitial lung fibroblasts | Scientific Reports

Blood type and breed-associated differences in cell marker expression on equine bone marrow-derived mesenchymal stem cells including major histocompatibility complex class II antigen expression | PLOS ONE
Blood type and breed-associated differences in cell marker expression on equine bone marrow-derived mesenchymal stem cells including major histocompatibility complex class II antigen expression | PLOS ONE